Last reviewed · How we verify
Pseudomonas Aeruginosa Infections
Approved treatments
- Coly-Mycin M · Ph Health
- colimycin · Poitiers University Hospital
- Coly-Mycin S · Par Sterile Products
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pseudomonas Aeruginosa Infections patent landscape — cliff calendar, originator estates, attackable patents
- Pseudomonas Aeruginosa Infections treatment landscape brief
- Pseudomonas Aeruginosa Infections treatment updates RSS
Frequently asked questions about Pseudomonas Aeruginosa Infections
What drugs treat Pseudomonas Aeruginosa Infections?
Tracked treatments include Coly-Mycin M, colimycin, Coly-Mycin S.
What is the treatment for Pseudomonas Aeruginosa Infections?
Standard treatment for Pseudomonas Aeruginosa Infections includes Coly-Mycin M, colimycin, Coly-Mycin S. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pseudomonas Aeruginosa Infections patent cliff · Pseudomonas Aeruginosa Infections CI report
- Treatment: Coly-Mycin M · Ph Health
- Treatment: colimycin · Poitiers University Hospital
- Treatment: Coly-Mycin S · Par Sterile Products
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing